Rapid reduction of substantially increased myoglobin and creatine kinase levels using a hemoadsorption device (CytoSorb®)—A case report

Abstract Rhabdomyolysis (RM) is a potentially life‐threatening entity that can lead to acute kidney injury (AKI). Continuous renal replacement therapy (CRRT) alone is known as effective therapy, but the additional use of a hemoadsorber (like CytoSorb®) might increase its efficacy.

Podrobná bibliografie

Hlavní autoři:	Erich Moresco, Christopher Rugg, Mathias Ströhle, Matthias Thoma
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2022-01-01
Edice:	Clinical Case Reports
Témata:	acute kidney injury CytoSorb® myoglobin renal replacement therapy rhabdomyolysis
On-line přístup:	https://doi.org/10.1002/ccr3.5272
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!